PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
PREPARE
PREhabilitation for Patients Awaiting a Liver Transplantation: The Development and Feasibility Testing of a Remote Multicomponent pREhabilitation Intervention: PREPARE
1 other identifier
interventional
20
1 country
1
Brief Summary
This is a study developing a prehabilitation intervention and then testing the acceptability and feasibility of the intervention. Start date Aug 2022 for Focus groups and Feb 2023 Co-design workshops and feasibility study date pending
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 24, 2022
CompletedFirst Submitted
Initial submission to the registry
May 3, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2024
CompletedDecember 20, 2023
December 1, 2023
2 years
May 3, 2023
December 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Recruitment
It will be presented in percentage form and will be defined by 1. Number of participants active on the list. 2. Number of participants eligible to participate. 3. Number of participants informed about the iPRehab study. 4. Number of participants who were interested in participating. 5. Number of participants recruited. 6. Number of participants interested but didn't recruit and reasons why. 7. Number of participants who own a computer/phone/tablet. 8. Number of participants who can use a computer/phone/tablet independently. 9. Number of participants who need support to use a device. Detail the support required. Min score 0% Max Score 100% Higher values indicate a higher recruitment rate.
6 months
Adherence
This will be recorded using percentage and will be defined by 1. Number of participants who attended 1:1 sessions. 2. Number of participants who attended the group exercise classes using a class log. 3. Number of participants who attend the online monthly peer support sessions while active on the liver transplantation waiting list. 4. Number of participants who accessed the website/web app. 5. Which sections of the website/web app are utilised and the number of participants who access each section. 6. Number of participants who wear the activity tracker and report weekly step count. Min score 0% Max Score 100% Higher values indicate a higher adherence rate.
6 months
Retention
This will be recorded using percentage and will be defined by 1. Number of participants who completed the baseline assessment. 2. Number of participants who completed the 12-week iPRehab study. 3. Number of participants who completed the assessment 1 week post the iPRehab study. 4. Number of participants who completed the assessment 12 weeks post the iPRehab study. 5. Number of participants who drop out and the reasons Min score 0% Max Score 100% Higher values indicate a higher retention rate.
6 months
Acceptability
This will be measured using an acceptability questionnaire. Min score 0% Max Score 100% Higher values indicate a higher acceptability.
6 months
Secondary Outcomes (2)
Physical function
6 months
Frailty
6 months
Study Arms (1)
Receiving the prehabilitation intervention
EXPERIMENTALAll participants will receive the prehabilitation intervention.
Interventions
Remote prehabilitation multi-component.
Eligibility Criteria
You may qualify if:
- on the transplant waiting list
- grade 3 below for encephalopathy
You may not qualify if:
- grade 4 above encephalopathy
- Known adverse reaction to exercise
- New stroke
- lacks capacity to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Belfast Health and Social Care Trustlead
- Queen's University, Belfastcollaborator
Study Sites (1)
Queen's University Belfast
Belfast, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roger McCorry, Dr
Belfast HSCT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2023
First Posted
September 13, 2023
Study Start
July 24, 2022
Primary Completion
July 24, 2024
Study Completion
September 27, 2024
Last Updated
December 20, 2023
Record last verified: 2023-12